一项Meta分析:抗炎药用植物对乳腺癌及健康围绝经期女性类更年期症状与心理问题的作用
该Meta分析纳入12项乳腺癌研究(917例)和15项健康围绝经期女性研究(2104例),评估药用植物补充剂(MPS)改善类更年期症状(MLS)的效果。结果显示MPS可改善Kupperman指数(KMI)和更年期评定量表(MRS)评分,乳腺癌患者改善幅度大于健康围绝经期女性,且乳腺癌患者KMI下降优于激素治疗组;两组应答率均显著提高、心理问题均减少,乳腺癌患者焦虑和失眠减轻。作者认为抗炎MPS可能帮助乳腺癌或健康围绝经期女性减轻MLS。
要点
- MPS可改善健康围绝经期女性和乳腺癌患者的KMI与MRS评分。
- 乳腺癌患者因治疗导致的KMI和MRS下降幅度大于健康围绝经期女性。
- 乳腺癌患者KMI下降较接受激素治疗者更显著。
核心结论
- 抗炎药用植物补充剂可能帮助乳腺癌女性或健康围绝经期女性减轻类更年期症状。
研究设计与样本
- 检索PubMed、Web of Science、Embase、Cochrane Library、中国知网、万方数据库和中国科技期刊数据库,检索时间自建库至2024年1月30日。
- 纳入随机对照试验,涉及健康围绝经期女性、接受草药治疗的乳腺癌患者及植物化合物对MLS的影响。
- 共纳入12项乳腺癌研究(917例)和15项健康围绝经期女性研究(2104例),使用Meta-mar工具分析数据。
主要发现
- 与对照相比,MPS改善了Kupperman指数(KMI)和更年期评定量表(MRS)评分。
- 乳腺癌患者因治疗导致的KMI和MRS下降幅度大于健康围绝经期女性。
- 乳腺癌患者KMI下降较接受激素治疗的女性更显著。
- 在健康围绝经期女性和乳腺癌患者中,MPS治疗的应答率均显著更高且心理问题更少。
- 乳腺癌患者经MPS治疗焦虑和失眠减轻;网络分析显示应答率是与MPS使用最相关的因素。
关键数值与推荐
- MPS改善KMI和MRS评分(与对照比较)。
- 乳腺癌患者KMI和MRS下降幅度大于健康围绝经期女性。
- 乳腺癌患者KMI下降较激素治疗组更显著。
- 健康围绝经期女性和乳腺癌患者中MPS组应答率显著更高、心理问题更少。
- 乳腺癌患者焦虑和失眠经MPS治疗减轻。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medicinal plant supplements (MPS) have benefits in improving menopause-like symptoms (MLS). OBJECTIVES: To investigate the effectiveness of MPS in reducing MLS in healthy women and those with breast cancer (BC). SEARCH STRATEGY: PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang database and Chinese Scientific Journals Database were searched from the date of library construction until 30 January 2024. SELECTION CRITERIA: Randomised controlled trials were selected that involved healthy perimenopausal women, BC patients treated with herbal medicines, and the effects of plant-based compounds on MLS. DATA COLLECTION AND ANALYSIS: The review included 12 studies with 917 patients with BC and 15 studies with 2104 healthy perimenopausal women. The data were analysed using the Meta-mar tool. MAIN RESULTS: MPS improved Kupperman's Index (KMI) and menopause rating scale (MRS) scores compared with the comparator. Patients with BC experienced a greater reduction in KMI and MRS because of treatment than healthy perimenopausal women. Patients with BC had a more significant reduction in KMI than women who received hormone therapy. In both healthy perimenopausal women and women with BC, MPS treatment resulted in significantly higher response rates and fewer psychological problems. Women with BC experienced a decrease in anxiety and insomnia by MPS. Network analysis showed that the response rate was the factor most associated with MPS use. CONCLUSIONS: Anti-inflammatory MPS may assist women with BC or healthy perimenopausal women experience less MLS.
引用
- Zhang F, Yang D. A Meta-Analysis: Anti-Inflammatory Medicinal Plants for Age-Related Menopause-Like Symptoms and Psychological Problems in Breast Cancer and Healthy Perimenopausal Women. BJOG. 2025. PMID: 40329882. doi:10.1111/1471-0528.18209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。